Effects of the downregulation of SnoN expression on HepG2 cell proliferation and apoptosis

Wenqi Wang1, Changhong Liu, Yiguo Wang

  • 1Department of Gastroenterology, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong 250014, P.R. China. wangwq62@163.com

Insights

Ski‑novel protein (SnoN) downregulation inhibits HepG2 cell proliferation and induces apoptosis. SnoN-specific small interfering RNA (siRNA) effectively reduces SnoN expression, offering a potential therapeutic strategy.

Area of Science:

  • Molecular Biology
  • Oncology

Background:

  • Ski‑novel protein (SnoN) is a proto‑oncogene implicated in cell growth and programmed cell death.
  • Understanding SnoN's role in hepatocellular carcinoma (HCC) is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the functional role of SnoN in HepG2 cell proliferation and apoptosis.
  • To evaluate the efficacy of small interfering RNA (siRNA) in downregulating SnoN expression in HepG2 cells.

Main Methods:

  • Three siRNAs targeting SnoN were designed and synthesized.
  • Inhibition efficiency was assessed using reverse transcription PCR (RT-PCR) and western blot.
  • Cell Counting Kit-8 (CCK-8) and flow cytometry were employed for proliferation and apoptosis analyses.

Main Results:

  • All synthesized siRNAs effectively inhibited SnoN expression, with siRNA-C showing optimal efficiency.
  • Downregulation of SnoN significantly inhibited HepG2 cell proliferation (P<0.05).
  • Significant induction of HepG2 cell apoptosis was observed following SnoN downregulation (P<0.05).

Conclusions:

  • SnoN-specific siRNA is effective in inhibiting SnoN expression in human HepG2 cells.
  • Downregulation of SnoN induces significant growth inhibition and apoptosis in HepG2 cells.
  • Targeting SnoN represents a promising strategy for HCC treatment.